MIGRAINE REFERENCES

Timothy C. Hain, MD, Chicago IL. Page last modified: December 21, 2012

We moved these references out of our main migraine page to make the main content easier to print.

• Causes
• Accompaniments
• Children
• Dizziness and hearing symptoms
• treatment
• Rebound
• White matter lesions
• Migraine and Meniere's disease
• Epidemiology

Migraine causes:

• Asghar, M. S., A. E. Hansen, et al. (2011). "Evidence for a vascular factor in migraine." Annals of neurology 69(4): 635-645.
• Cady, R. K. (2007). "The convergence hypothesis." Headache 47 Suppl 1: S44-51.
• Da Silva A, Granziera C, Snyder J, Hadjikhani M. Thickening of somatosensory cortex of patients with Migraine. Neurology 2007, 69, 1990-1995
• Denuelle M, and others.  A PET study of photophobia during spontaneous migraine attacks.  Neurology 2011:76:213-218
• Evans RW, Olesen J. Migraine classification, diagnostic criteria and testing. Neurology 2003:60(Suppl 2) 24-30
• Gasbarrini A, and others. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology, 1998;45:765-70
• Goadsby PH. Migraine, aura and spreading depression: Why are we still talking about it ? Ann Neurol, 2001, 59, 5-6.
• Lipton RB and others. Migraine in the United States. Epidemiology and patterns of health care use. Neurology 2002:58:885-894
• Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data. Cephalgia 1998:18:1874-82
• Mitsikostas DD, Sfikakis PP and Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth(Brain, Vol. 127, No. 5, 1200-1209, 2004)
  
• Meyer JS et al. Reversible cognitive decline accompanies migraine and cluster headache. Headache 2000:40:638-646
• Oh, S. Y., M. W. Seo, et al. (2009). "Gaze-evoked and rebound nystagmus in a case of migrainous vertigo." Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 29(1): 26-28.
• Olesen, J. (1991). "Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs." Pain 46(2): 125-132.
• Rozen et al. Increasing incidence of medically recognized migraine headache in a United States population. Neurology 1999:53:1468-1473
• Silberstein SD. Practice parameter: evidence based guidelines for migraine headache (an evidence-based review). Neurology 2000:55:754-763
• Schreiber CP and others. Prevalence of migraine in patients with a history of self-reported or physician diagnosed "Sinus" headache. Arch Int Med. 2004: 164: 1769-1772
• Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population based studies. Neurology 44 (suppl 4) S17-S23, 1994
• Tzourio C and others. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology 2001:56;1273-1277

Migraine accompaniments involving hypersensitivity

• Aurora, S. K. and F. Wilkinson (2007). "The brain is hyperexcitable in migraine." Cephalalgia 27(12): 1442-1453.
• Blau, J. N. and F. Solomon (1985). "Smell and other sensory disturbances in migraine." J Neurol 232(5): 275-276.
• Boulloche, N., M. Denuelle, et al. (2010). "Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain." J Neurol Neurosurg Psychiatry.
• De Carlo, D., I. Toldo, et al. (2012). "Osmophobia as an early marker of migraine: a follow-up study in juvenile patients." Cephalalgia 32(5): 401-406.
• Gunaydin, S., A. Soysal, et al. (2006). "Motor and occipital cortex excitability in migraine patients." Can J Neurol Sci 33(1): 63-67.
• Lipton, R. B., M. E. Bigal, et al. (2008). "Cutaneous allodynia in the migraine population." Ann Neurol 63(2): 148-158.
• Kelman, L. (2004). "The place of osmophobia and taste abnormalities in migraine classification: a tertiary care study of 1237 patients." Cephalalgia 24(11): 940-946.
• Miller, C. S. (2001). "The compelling anomaly of chemical intolerance." Ann N Y Acad Sci 933: 1-23.
• Vingen, J. V., J. A. Pareja, et al. (1998). "Phonophobia in migraine." Cephalalgia 18(5): 243-249.
• Young, W. B. (2009). "Allodynia as a complication of migraine: background and management." Curr Treat Options Neurol 11(1): 3-9.

Migraine in children

• Barabas G, Matthews WS, Ferrari M. childhood migraine and motion sickness. Pediatrics 72:188-190, 1983
• Bille B: Migraine in School Children. Acta Pediatrifa 51 (s136) 3-151, 1962
• Mortimer MJ et al. Develop Med and Child Neurol 34:1095-1101, 1992.
• Mortimer MJ et al. Headache 33;427-431, 1993

Migraine and dizziness or vertigo or hearing symptoms

• Allena, M., D. Magis, et al. (2007). "The vestibulo-collic reflex is abnormal in migraine." Cephalalgia 27(10): 1150-1155.
• Battista R. Audiometric findings of patients with migraine-associated dizziness. Otol and Neurol 25:987-992, 2004
• Bickerstaff ER. Basilar artery migraine. Lancet 1:15, 1961
• Cass, SP, Furman JM, Ankerstjerne, JK. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106: 182-89, 1997
• Cha, Y. H., H. Lee, et al. (2009). "Association of benign recurrent vertigo and migraine in 208 patients." Cephalalgia 29(5): 550-555.
• Cutrer FM, Baloh RW. Migraine associated Dizziness. Headache 32:300-304, 1992
• Eadie MJ. Some aspects of episodic giddiness. Med J. Australia 2:453, 1960
• Hamed SA, Youssef AH, Elattar AM. Assessment of cochlear and auditory pathways in patients with migraine. Am J Otolaryngol. 2011 Nov 29. [Epub ahead of print]
• Harker LA. Migraine-associated Vertigo in Disorders of the Vestibular System (ed. Baloh, Halmagyi, 1996) Oxford.
• Gupta VK. Migraine associated hypotension and autonomic ganglionitis. Letter in Neurology, 1997, 49, 1186
• Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109:377-380
• Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope, 108 (Suppl 85):1-28, 1998
• Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 107:1123, 1984
• Kuritzky A, Toglias UJ, Thomas D. Vestibular function in Migraine. Headache 21:110-112, 1981
• Kuritsky A, Ziegler D, Hassanein R. Vertigo, motion sickness and migraine. Headache 21, 227-231, 1981
• Lee H et al. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res 2002; 24: 663-665
• Leliever WC, Barber HO. Recurrent vestibulopathy. Laryngoscope 1981:91:1-6
• Neuhauser, H. K., A. Radtke, M. von Brevern, et al. (2006). "Migrainous vertigo: prevalence and impact on quality of life." Neurology67(6): 1028-33.
• Olsson JE. Neurotologic findings in basilar migraine. Laryngoscope 101:1-41, 1991
• Ophoff RA and others. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87;543-552
• Polensek, S. H. and R. J. Tusa (2010). "Nystagmus during attacks of vestibular migraine: an aid in diagnosis." Audiol Neurootol 15(4): 241-246.
• Reploeg MD, Goebel JA. Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 23:364-371, 2002
• Savundra PA, Carroll JD, Davies RA, Luxon LM. Migraine-associated vertigo. Cephalgia 17(4) 505-510, 1997
• Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular disorders. J. Neurol Neurosurg Psych 23:23, 1960
• Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psych 42:363, 1979
• Tusa RJ. Diagnosis and Management of Neuro-otologic disorders due to migraine., ICS Medical Report, July 1999
• Uneri A (2004). Migraine and benign paroxysmal positional vertigo: An outcome study of 476 patients. ENT journal Dec 2004, 83, 12, 814-815.
• Virre ES, Baloh RW. Migraine as a cause of sudden hearing loss. Headache. 36(1):24-8, 1996
• Waterston J. Chronic migrainous vertigo. J. Clin Neurosci (2004) 11(4) 384-388

Migraine treatment:

• Bisdorf A. Treatment of migraine associated vertigo with Lamotrigine. An observational study. Bull Soc Sci Med, 2004, 103-108. Comment: an uncontrolled study of 19 individuals.
• Boska M.D. and others. Contrasts in cortical magnesium ... between migraine syndromes. Neurology 2002:58:1227-1233
• Charles A, Flippen C, Romero Reyes M, Brennan KC.J Headache Pain. 2007 Sep;8(4):248-50. Epub 2007 Sep 24. Memantine for prevention of migraine: a retrospective study of 60 cases.
  Cutrer FM, Limmoth V, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalgia 1997:17:93-100
• Farkkila, M., J. Olesen, et al. (2003). "Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan." Cephalalgia 23(6): 463-71.
• Furman, J. M., D. A. Marcus, et al. (2011). "Rizatriptan reduces vestibular-induced motion sickness in migraineurs." The journal of headache and pain 12(1): 81-88.
• Geroud G, Keywood C, Senared JM. Migraine headache recurrence ... Headache 2003:43:376-388
• Krusz J-C. Oxcarbazepine is effective in chronic migraine prophylaxis (abstract). Cephalagia 2000;20(4):425. Abstract 394
• Maassenvandenbrink et al. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998:98:25-30.
• Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data. Cephalgia 1998:18:1874-82
• Ryan R and others. Neurology 1997:49:1225-1230
• Foster CA, Bafaloukos J. paroxetine in the treatment of chronic daily headache. Headache 1994:34(10):587-9
• Gaist D and others. Inappropriate use of sumatriptan: population-based register and interview study. BMJ 1998, 316, 1352-3
• Goadsby PJ, Hoskin KH. Ann Neurol 1998:43:711-718
• Goadsby PJ., Lipton RB, Ferrari MD. Migraine -- current understanding and treatment. NEJM Jan 24, 2002, p 261
• Jenson M et al. Efficacy of oxcarbazepine in migraine: a prospectice open label trial (abstract). Ann meeting of the Am. Headache Society, 2002, Jun 21-23, Abstract S-96
• Limroth V, Kazarawa Z, Fritsche G, Diener H. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
• Langemark M, lesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind study. Headache 1994;31(1):20-4
• Lipton and others. Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache 2000:40, #10)
• Lipton and many others. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63:148-158
• Maasenvabdebrrink et al. 5-Ht1b receptor polymorphism and clinical response to sumatriptan. Headache 1998:38:288-291. Comment: 5HT-1b Receptor polymorphism does not explain response variability.
• Nett RB, Krusz JC. Oxcarbazepine prophylaxis for chronic migraine and tension-type headache (abstract). Cephalgia 2002:22(7); 608-PB.35
• Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF.J Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.Pharmacol Exp Ther. 2007 May;321(2):564-72. Epub 2007 Jan 31.
• Sandrini, G., M. Farkkila, et al. (2002). "Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study." Neurology 59(8): 1210-7.
• Silberstein SD. Practice parameter: evidence based guidelines for migraine headache (an evidence-based review). Neurology 2000:55:754-763
• Silberstein et al, Acute migraine treatment with droperidol: A randomized double-blind placebo-controlled trial. Neurology 60, p315-321, 2003
• Yu W, ZHorowitz S. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003:60:120-121

Rebound headache

• Seminars in Headache Medicine, Analgesic Rebound Headache, Vol #2, #3, Sept 1997.
• Begal M, Liptan R. Excessive acute migraine medication use and migraine progression. Neurology 2008:71:1821-1828
• Napoli and many others. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009;72; 2111-2114

Migraine and Meniere's disease

• Radke A, Lempert T, Gresty MA and others. Migraine and Meniere's disease: Is there a link ? Neurology 59, 11, 1700-1704, 2002
• Rassekh CH, Harker LA. The prevalence of migraine in Meniere's disease. Laryngoscope 102:135-8, 1992

White matter lesions in migraine

• Dahlof, C. G., P. Linton-Dahlof, et al. (2005). "[Is migraine a progressive cerebral disease?]." Neurologia 20(7): 356-65.
• De Benedittis, G., A. Lorenzetti, et al. (1995). "Magnetic resonance imaging in migraine and tension-type headache." Headache 35(5): 264-8.
• Palm-Meinders I, and many others. Structural brain changes in migraine. JAMA 11/14/2012, 308 (18), 1189-1897

Migraine epidemiology

• Lipton RB and others. Migraine in the United States. Epidemiology and patterns of health care use. Neurology 2002:58:885-894
• Manback A, Buse DC, Serrano D, Turkel CC, Lipton RB. Rates, predictors and consequences of remission from chronic migraine to episodic migraine. Neurology 2011;76:711-718
• Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 199:119 355-361 (about 15-20% of migraines are with aura
• Rozen, T. D. and R. S. Fishman (2012). "Female cluster headache in the United States of America: what are the gender differences? Results from the United States Cluster Headache Survey." J Neurol Sci 317(1-2): 17-28.
• Brewerton, T. D. and M. S. George (1990). "A study of the seasonal variation of migraine." Headache 30(8): 511-513.